Giles Platford Discusses Strengthening the Plasma Ecosystem for Patients Worldwide at PPF2025
Giles Platford, President, Plasma-Derived Therapies Business Unit at Takeda and Chair of the Global Executive Board at PPTA, shared on LinkedIn:
”At this year’s Plasma Protein Forum, it was rewarding to join colleagues and partners from across the industry in conversations focused on strengthening sustainability of the plasma ecosystem, and advancing access to PDTs.
We heard from many compelling speakers, and I appreciated the contributions of my Takeda colleagues in sharing their expertise to advance knowledge across the value chain.
Thomas R. Kreil offered important perspectives on innovations in plasma testing and manufacturing, while Thomas Szatkowski demonstrated tangible examples of how we are applying AI and machine learning to transform the way we collect, process and deliver plasma therapies.
The meeting also placed considerable emphasis on navigating the regulatory uncertainties we face both in the US and globally, centering, as always, the needs of patients and donors.
Thank you to the Plasma Protein Therapeutics Association (PPTA) for convening such an engaging and forward-looking forum.
These moments of shared learning and collaboration are essential as we work together to ensure more patients can benefit from the life-saving potential of plasma.”
More from PPF2025 featured in Hemostasis Today.
-
Sep 10, 2026, 15:36Majdouline El Moussaoui: What If AA Amyloidosis is the First Clue to an Undiagnosed Monogenic Autoinflammatory Disease?
-
Sep 10, 2026, 15:21Pathogenesis and Emerging Targeted Therapies in Myeloproliferative Neoplasms – NEJM Group
-
Sep 10, 2026, 15:06YSMU Remembers Honorary Doctor and Nobel Laureate Prof. Ada Yonath
-
Sep 10, 2026, 14:39Piotr Czempik: ROTEM Guided Anticoagulation in Severe Thrombocytopenia and Acute VTE
-
Sep 10, 2026, 14:30Adil Aftab: Acute VTE Treatment and Anticoagulation Considerations in Renal Dysfunction
-
Sep 10, 2026, 14:21Seth Green: Testosterone Replacement Therapy and VTE Risk When Is the Risk Highest
-
Sep 10, 2026, 13:56Sumyea Kabir: Wet Hijama and Blood Donation Why Deferral Matters
-
Sep 10, 2026, 11:56William Pao: Celebrating a Landmark Breakthrough in Hemophilia Care
-
Sep 10, 2026, 11:25Andreas Glenthøj: New Sickle Cell Trait Data in UpToDate